MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) Form 10-K Annual Reports
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MRVI
CIK: 1823239
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerKC Freer
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-09 | 2026-10-08 | FORM 4 | 0001380632-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | FORM 4 | 0001600301-26-000008 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-29 | — | SCHEDULE 13G Filing | 0001104659-26-112023 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | FORM 4 | 0001380632-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-31 | FORM 4 | 0001600301-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001398344-26-014381 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | FORM 4 | 0001380632-26-000006 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001823239-26-000059 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001823239-26-000056 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | FORM 4 | 0001600301-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | FORM 4 | 0001380632-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0001600301-26-000002 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-29 | — | SCHEDULE 13G Filing | 0001104659-26-078987 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-23 | — | SCHEDULE 13G Filing | 0001104659-26-076907 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | FORM 4 | 0001380632-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | FORM 4 | 0001832579-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | FORM 4 | 0001251299-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-06-10 | — | 144 Filing | 0001959173-26-004507 | View SEC Doc Filr Page |
| 144 | 2026-06-09 | — | 144 Filing | 0001959173-26-004463 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-02 | 8-K | 0001823239-26-000049 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-26 | 8-K | 0001823239-26-000046 | View SEC Doc Filr Page |
| 4/A | 2026-05-28 | 2026-05-26 | FORM 4/A | 0001251299-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-26 | FORM 4 | 0001829810-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-26 | FORM 4 | 0001833453-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-26 | FORM 4 | 0001262930-26-000001 | View SEC Doc Filr Page |